|
Volumn 25, Issue 4, 2006, Pages 495-500
|
Phase I clinical trail of intravenous pegylated recombinant human granulocyte colony-stimulating factor
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CD34 ANTIGEN;
MACROGOL DERIVATIVE;
PACLITAXEL;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ADULT;
AGED;
ARTHRALGIA;
ARTICLE;
BLOOD CELL COUNT;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
CHEMISTRY;
CLINICAL TRIAL;
CYTOLOGY;
FATIGUE;
FEMALE;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
METABOLISM;
MIDDLE AGED;
NEUTROPENIA;
NEUTROPHIL;
PATHOLOGY;
PHASE 1 CLINICAL TRIAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
ADULT;
AGED;
ANTIGENS, CD34;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ARTHRALGIA;
BLOOD CELL COUNT;
BREAST NEOPLASMS;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
FATIGUE;
FEMALE;
GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEUTROPENIA;
NEUTROPHILS;
PACLITAXEL;
POLYETHYLENE GLYCOLS;
|
EID: 66049118426
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (13)
|
References (0)
|